CBP-4888

DRUG2 trials

Sponsors

Comanche Biopharma

Conditions

Healthy Volunteer StudyPreeclampsiaPreterm PreeclampsiasFlt1 Mediated Preterm Preeclampsia

Early Phase 1

Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects

CompletedNCT05881993

Comanche BiopharmaHealthy Volunteer Study

Start: 2023-05-22End: 2024-05-22Updated: 2025-09-26

Phase 1

A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months

RecruitingNCT07282171

Comanche BiopharmaPreeclampsia, Preterm Preeclampsia, sFlt1 Mediated Preterm Preeclampsia

Start: 2025-02-26End: 2029-03-31Target: 60Updated: 2026-05-18